Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic Utilization

References

• Mulhall JP, Giraldi A, Hackett G, et al. The 2018 revision to the process of care model for management of erectile dysfunction. J Sex Med. 2018;15(10):1434–1445. doi:10.1016/j.jsxm.2018.05.021
   PubMed Web of Science ®Google Scholar
• Das S, Jiang X, Jiang W, Ting TY, Polli JE. Relationship of antiepileptic drugs to generic brittleness in patients with epilepsy. Epilepsy Behav. 2020;105:106936. doi:10.1016/j.yebeh.2020.106936
   PubMed Web of Science ®Google Scholar
• Chaluvadi S, Chiang S, Tran L, Goldsmith CE, Friedman DE. Clinical experience with generic levetiracetam in people with epilepsy. Epilepsia. 2011;52(4):810–815. doi:10.1111/j.1528-1167.2011.03025.x
   PubMed Web of Science ®Google Scholar
• Lang JD, Kostev K, Onugoren MD, et al. Switching the manufacturer of antiepileptic drugs is associated with higher risk of seizures: a nationwide study of prescription data in Germany. Ann Neurol. 2018;84(6):918–925. doi:10.1002/ana.25353
   PubMed Web of Science ®Google Scholar
• Corrao G, Soranna D, Arfe A, et al. Are generic and brand-name statins clinically equivalent? Evidence from a real data-base. Eur J Intern Med. 2014;25(8):745–750. doi:10.1016/j.ejim.2014.08.002
   PubMed Web of Science ®Google Scholar
• Corrao G, Soranna D, Merlino L, Mancia G. Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based study. Eur J Clin Invest. 2014;44(10):933–939. doi:10.1111/eci.12326
   PubMed Web of Science ®Google Scholar
• Jackevicius CA, Tu JV, Krumholz HM, et al. Comparative effectiveness of generic atorvastatin and lipitor® in patients hospitalized with an acute coronary syndrome. J Am Heart Assoc. 2016;5(4):e003350. doi:10.1161/JAHA.116.003350
   PubMed Web of Science ®Google Scholar
• Kesselheim AS, Misono AS, Lee JL, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21):2514–2526. doi:10.1001/jama.2008.758
   PubMed Web of Science ®Google Scholar
• Desai RJ, Sarpatwari A, Dejene S, et al. Comparative effectiveness of generic and brand-name medication use: a database study of US health insurance claims. PLoS Med. 2019;16(3):e1002763. doi:10.1371/journal.pmed.1002763
   PubMed Web of Science ®Google Scholar
• Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Medication adherence and use of generic drug therapies. Am J Manag Care. 2009;15(7):450–456.
   PubMed Web of Science ®Google Scholar
• Shrank WH, Liberman JN, Fischer MA, et al. The consequences of requesting ”dispense as written”. Am J Med. 2011;124(4):309–317. doi:10.1016/j.amjmed.2010.11.020
   PubMed Web of Science ®Google Scholar
• Kesselheim AS, Gagne JJ, Franklin JM, et al. Variations in patients’ perceptions and use of generic drugs: results of a national survey. J Gen Intern Med. 2016;31(6):609–614. doi:10.1007/s11606-016-3612-7
   PubMed Web of Science ®Google Scholar
• Shrank WH, Cox ER, Fischer MA, Mehta J, Choudhry NK. Patients’ perceptions of generic medications. Health Aff. 2009;28(2):546–556. doi:10.1377/hlthaff.28.2.546
   PubMed Web of Science ®Google Scholar
• Kesselheim AS, Gagne JJ, Eddings W, et al. Prevalence and predictors of generic drug skepticism among physicians: results of a national survey. JAMA Intern Med. 2016;176(6):845–847. doi:10.1001/jamainternmed.2016.1688
   PubMed Web of Science ®Google Scholar
• Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015;13(1):173. doi:10.1186/s12916-015-0415-3
   PubMed Web of Science ®Google Scholar
• Hassali MAA, Shafie AA, Jamshed S, Ibrahim MIM, Awaisu A. Consumers’ views on generic medicines: a review of the literature. Int J Pharm Pract. 2009;17(2):79–88. doi:10.1211/ijpp/17.02.0002
   PubMedGoogle Scholar
• Dunne SS. What do users of generic medicines think of them? A systematic review of consumers’ and patients’ perceptions of, and experiences with, generic medicines. Patient. 2016;9(6):499–510. doi:10.1007/s40271-016-0176-x
   PubMedGoogle Scholar
• FDA List of authorized generic drugs. Available from: https://www.fda.gov/drugs/abbreviated-new-drug-application-anda/fda-list-authorized-generic-drugs. Accessed August 19, 2020.
   Google Scholar
• Hansen RA, Qian J, Berg R, et al. Comparison of generic-to-brand switchback rates between generic and authorized generic drugs. Pharmacotherapy. 2017;37(4):429–437. doi:10.1002/phar.1908
   PubMed Web of Science ®Google Scholar
• Desai RJ, Sarpatwari A, Dejene S, et al. Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study. BMJ. 2018;361:k1180. doi:10.1136/bmj.k1180
   PubMed Web of Science ®Google Scholar
• Zarmpi P, Flanagan T, Meehan E, Mann J, Fotaki N. Biopharmaceutical aspects and implications of excipient variability in drug product performance. Eur J Pharm Biopharm. 2017;111:1–15. doi:10.1016/j.ejpb.2016.11.004
   PubMed Web of Science ®Google Scholar
• Page A, Etherton-Beer C. Choosing a medication brand: excipients, food intolerance and prescribing in older people. Maturitas. 2018;107:103–109. doi:10.1016/j.maturitas.2017.11.001
   PubMed Web of Science ®Google Scholar
• Latwal B, Chandra A. Authorized generics vs. branded generics: a perspective. J Generic Med. 2021;17(1):5–9. doi:10.1177/1741134320947773
   Google Scholar
• Bingel U. For the placebo competence T. Avoiding Nocebo effects to optimize treatment outcome. JAMA. 2014;312(7):693–694. doi:10.1001/jama.2014.8342
   PubMed Web of Science ®Google Scholar
• Berg MJ, Gross RA, Haskins LS, Zingaro WM, Tomaszewski KJ. Generic substitution in the treatment of epilepsy: patient and physician perceptions. Epilepsy Behav. 2008;13(4):693–699. doi:10.1016/j.yebeh.2008.06.001
   PubMed Web of Science ®Google Scholar
• Johnston A. Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantation. Eur J Hosp Pharm Sci Pract. 2013;20(5):302. doi:10.1136/ejhpharm-2012-000258
   PubMedGoogle Scholar
• Tamblyn R, Eguale T, Huang A, Winslade N, Doran P. The incidence and determinants of primary nonadherence with prescribed medication in primary care: a cohort study. Ann Intern Med. 2014;160(7):441–450. doi:10.7326/M13-1705
   PubMed Web of Science ®Google Scholar
• Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. 2011;30(1):91–99. doi:10.1377/hlthaff.2009.1087
   PubMed Web of Science ®Google Scholar